

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to peptidoglycan (GO:0032494) | 5.05960749 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 4.92822833 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.92822833 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.92822833 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.92822833 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 4.92822833 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.92822833 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.80383450 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 4.55093445 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.49573815 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.49573815 |
| 12 | negative regulation of interleukin-12 production (GO:0032695) | 4.23933884 |
| 13 | detection of other organism (GO:0098543) | 4.18333883 |
| 14 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.14045107 |
| 15 | detection of bacterium (GO:0016045) | 3.97080049 |
| 16 | response to muramyl dipeptide (GO:0032495) | 3.90821628 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 3.89490153 |
| 18 | detection of molecule of bacterial origin (GO:0032490) | 3.70497236 |
| 19 | regulation of gamma-delta T cell activation (GO:0046643) | 3.67988874 |
| 20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.67662984 |
| 21 | germinal center formation (GO:0002467) | 3.66628417 |
| 22 | detection of external biotic stimulus (GO:0098581) | 3.62957287 |
| 23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.57099848 |
| 24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.57057085 |
| 25 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.52807665 |
| 26 | cellular extravasation (GO:0045123) | 3.49606368 |
| 27 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.46517423 |
| 28 | immunoglobulin mediated immune response (GO:0016064) | 3.43717428 |
| 29 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.43328806 |
| 30 | regulation of mast cell degranulation (GO:0043304) | 3.32313593 |
| 31 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.31619806 |
| 32 | response to host immune response (GO:0052572) | 3.28122479 |
| 33 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.28122479 |
| 34 | regulation of leukocyte degranulation (GO:0043300) | 3.25596744 |
| 35 | detection of biotic stimulus (GO:0009595) | 3.24918811 |
| 36 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.21319068 |
| 37 | leukocyte aggregation (GO:0070486) | 3.14655372 |
| 38 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.12646685 |
| 39 | response to host (GO:0075136) | 3.12646685 |
| 40 | response to host defenses (GO:0052200) | 3.12646685 |
| 41 | macrophage activation (GO:0042116) | 3.12271087 |
| 42 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.09224717 |
| 43 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.04733359 |
| 44 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.02598785 |
| 45 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.00700377 |
| 46 | respiratory burst (GO:0045730) | 2.99098387 |
| 47 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.96135887 |
| 48 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.94948113 |
| 49 | type I interferon signaling pathway (GO:0060337) | 2.94430709 |
| 50 | cellular response to type I interferon (GO:0071357) | 2.94430709 |
| 51 | NIK/NF-kappaB signaling (GO:0038061) | 2.94419753 |
| 52 | response to type I interferon (GO:0034340) | 2.93727185 |
| 53 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.92598803 |
| 54 | granulocyte activation (GO:0036230) | 2.91044515 |
| 55 | mannose metabolic process (GO:0006013) | 2.89678702 |
| 56 | myeloid cell activation involved in immune response (GO:0002275) | 2.89534437 |
| 57 | neutrophil activation (GO:0042119) | 2.86762517 |
| 58 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.84963218 |
| 59 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.81409724 |
| 60 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.80855908 |
| 61 | B cell receptor signaling pathway (GO:0050853) | 2.79845521 |
| 62 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.77117815 |
| 63 | microglial cell activation (GO:0001774) | 2.77087217 |
| 64 | defense response to protozoan (GO:0042832) | 2.76736252 |
| 65 | protein localization to endosome (GO:0036010) | 2.75590672 |
| 66 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.73370846 |
| 67 | T-helper 1 type immune response (GO:0042088) | 2.72301979 |
| 68 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.71948817 |
| 69 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.71918738 |
| 70 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.71516466 |
| 71 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.71328271 |
| 72 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.70754967 |
| 73 | negative regulation of T cell mediated immunity (GO:0002710) | 2.69801614 |
| 74 | positive regulation of interferon-alpha production (GO:0032727) | 2.67602515 |
| 75 | regulation of necroptotic process (GO:0060544) | 2.67592747 |
| 76 | regulation of regulated secretory pathway (GO:1903305) | 2.66787846 |
| 77 | positive regulation of mast cell activation (GO:0033005) | 2.65254822 |
| 78 | regulation of interferon-alpha production (GO:0032647) | 2.64761312 |
| 79 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.64715290 |
| 80 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.63884189 |
| 81 | response to protozoan (GO:0001562) | 2.63761666 |
| 82 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.63006568 |
| 83 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.62500889 |
| 84 | positive regulation of type 2 immune response (GO:0002830) | 2.60019005 |
| 85 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.57061943 |
| 86 | regulation of macrophage cytokine production (GO:0010935) | 2.51889210 |
| 87 | regulation of T cell tolerance induction (GO:0002664) | 2.51737837 |
| 88 | response to laminar fluid shear stress (GO:0034616) | 2.51723492 |
| 89 | positive thymic T cell selection (GO:0045059) | 2.51227591 |
| 90 | myeloid dendritic cell differentiation (GO:0043011) | 2.50087789 |
| 91 | regulation of tolerance induction (GO:0002643) | 2.49983221 |
| 92 | regulation of mast cell activation (GO:0033003) | 2.49675224 |
| 93 | positive regulation of B cell differentiation (GO:0045579) | 2.48080725 |
| 94 | modulation by symbiont of host cellular process (GO:0044068) | 2.47635014 |
| 95 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.46422397 |
| 96 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.46122516 |
| 97 | positive regulation of mast cell degranulation (GO:0043306) | 2.46122516 |
| 98 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.45362202 |
| 99 | regulation of antigen processing and presentation (GO:0002577) | 2.44762063 |
| 100 | negative regulation of interleukin-6 production (GO:0032715) | 2.43629168 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.95124144 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.32628454 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.12467089 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.74271609 |
| 5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.73236453 |
| 6 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.73008118 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 2.64066119 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.60748398 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.59953153 |
| 10 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.48663462 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.46603793 |
| 12 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.46061704 |
| 13 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.39164773 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.38521971 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.38038614 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.34859516 |
| 17 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.32140633 |
| 18 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.26571998 |
| 19 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.26504961 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.26241061 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.22610012 |
| 22 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.17248979 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.08543073 |
| 24 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.06237894 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 1.99537711 |
| 26 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.99428602 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.96034376 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.95993594 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.95841148 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.83244900 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82682565 |
| 32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.79763753 |
| 33 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.78575685 |
| 34 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.74712431 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.70203661 |
| 36 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.65380364 |
| 37 | KDM2B_26808549_Chip-Seq_K562_Human | 1.65256913 |
| 38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.60510438 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.60214999 |
| 40 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59909388 |
| 41 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.59471288 |
| 42 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.58848848 |
| 43 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.58527230 |
| 44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57844162 |
| 45 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.56819626 |
| 46 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.55367411 |
| 47 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.54693181 |
| 48 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.51290955 |
| 49 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.50856840 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.50279820 |
| 51 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.49596372 |
| 52 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.48455687 |
| 53 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.46185057 |
| 54 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.38281332 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.35940508 |
| 56 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.35267491 |
| 57 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.32983861 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32975160 |
| 59 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.31359609 |
| 60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30528861 |
| 61 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.29172214 |
| 62 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25656865 |
| 63 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.25339978 |
| 64 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22690791 |
| 65 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20884641 |
| 66 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20658895 |
| 67 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20233072 |
| 68 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17606992 |
| 69 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16910854 |
| 70 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16008873 |
| 71 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.15482765 |
| 72 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14544269 |
| 73 | MYB_26560356_Chip-Seq_TH2_Human | 1.13990373 |
| 74 | MYB_26560356_Chip-Seq_TH1_Human | 1.13327264 |
| 75 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.12977291 |
| 76 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.12282996 |
| 77 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10978645 |
| 78 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.10442370 |
| 79 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09196026 |
| 80 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08390575 |
| 81 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07978956 |
| 82 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.06484737 |
| 83 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06152906 |
| 84 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05810325 |
| 85 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05723940 |
| 86 | P68_20966046_ChIP-Seq_HELA_Human | 1.04698141 |
| 87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02672508 |
| 88 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99290732 |
| 89 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98457921 |
| 90 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97602216 |
| 91 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97365337 |
| 92 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.97217183 |
| 93 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94884922 |
| 94 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.94557975 |
| 95 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.94557975 |
| 96 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94449050 |
| 97 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94317706 |
| 98 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.93781423 |
| 99 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93750952 |
| 100 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92020906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.47103750 |
| 2 | MP0003436_decreased_susceptibility_to | 3.72141757 |
| 3 | MP0003724_increased_susceptibility_to | 3.17159736 |
| 4 | MP0005451_abnormal_body_composition | 3.06603367 |
| 5 | MP0003300_gastrointestinal_ulcer | 2.87215598 |
| 6 | MP0005058_abnormal_lysosome_morphology | 2.77643984 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.69753414 |
| 8 | MP0002419_abnormal_innate_immunity | 2.67490814 |
| 9 | MP0004510_myositis | 2.52075372 |
| 10 | MP0005387_immune_system_phenotype | 2.44363113 |
| 11 | MP0001790_abnormal_immune_system | 2.44363113 |
| 12 | MP0005025_abnormal_response_to | 2.44217990 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.33935214 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.32878504 |
| 15 | MP0009278_abnormal_bone_marrow | 2.32187405 |
| 16 | MP0006082_CNS_inflammation | 2.31447420 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.30188951 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.29860647 |
| 19 | MP0000685_abnormal_immune_system | 2.27706811 |
| 20 | MP0009785_altered_susceptibility_to | 2.26837713 |
| 21 | MP0005671_abnormal_response_to | 2.16313096 |
| 22 | MP0001800_abnormal_humoral_immune | 2.13189002 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.05581907 |
| 24 | MP0002452_abnormal_antigen_presenting | 2.03078844 |
| 25 | MP0002723_abnormal_immune_serum | 2.02156828 |
| 26 | MP0008260_abnormal_autophagy | 1.98434052 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.93011397 |
| 28 | MP0002420_abnormal_adaptive_immunity | 1.90099046 |
| 29 | MP0001819_abnormal_immune_cell | 1.89668483 |
| 30 | MP0004947_skin_inflammation | 1.89335270 |
| 31 | MP0009840_abnormal_foam_cell | 1.86519488 |
| 32 | MP0003828_pulmonary_edema | 1.85554577 |
| 33 | MP0005464_abnormal_platelet_physiology | 1.70879002 |
| 34 | MP0003075_altered_response_to | 1.66685909 |
| 35 | MP0002998_abnormal_bone_remodeling | 1.66075583 |
| 36 | MP0003763_abnormal_thymus_physiology | 1.58849148 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.56000101 |
| 38 | MP0002405_respiratory_system_inflammati | 1.54693587 |
| 39 | MP0000858_altered_metastatic_potential | 1.49907560 |
| 40 | MP0003453_abnormal_keratinocyte_physiol | 1.44810466 |
| 41 | MP0005076_abnormal_cell_differentiation | 1.44262384 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.42157457 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.40133953 |
| 44 | MP0000716_abnormal_immune_system | 1.39847389 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.39325593 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.39325593 |
| 47 | MP0002398_abnormal_bone_marrow | 1.33314329 |
| 48 | MP0003690_abnormal_glial_cell | 1.31500667 |
| 49 | MP0001849_ear_inflammation | 1.30350186 |
| 50 | MP0003091_abnormal_cell_migration | 1.30222366 |
| 51 | MP0002332_abnormal_exercise_endurance | 1.30147796 |
| 52 | MP0008004_abnormal_stomach_pH | 1.28639147 |
| 53 | MP0000343_altered_response_to | 1.27372032 |
| 54 | MP0008469_abnormal_protein_level | 1.25276576 |
| 55 | MP0005166_decreased_susceptibility_to | 1.20789278 |
| 56 | MP0000604_amyloidosis | 1.16939070 |
| 57 | MP0003183_abnormal_peptide_metabolism | 1.16678321 |
| 58 | MP0009764_decreased_sensitivity_to | 1.16068293 |
| 59 | MP0004858_abnormal_nervous_system | 1.13904975 |
| 60 | MP0005167_abnormal_blood-brain_barrier | 1.13094978 |
| 61 | MP0005409_darkened_coat_color | 1.12660429 |
| 62 | MP0002429_abnormal_blood_cell | 1.09261496 |
| 63 | MP0005310_abnormal_salivary_gland | 1.07001114 |
| 64 | MP0002722_abnormal_immune_system | 1.06531809 |
| 65 | MP0003566_abnormal_cell_adhesion | 1.05895966 |
| 66 | MP0003646_muscle_fatigue | 1.04700244 |
| 67 | MP0001853_heart_inflammation | 1.04125491 |
| 68 | MP0004130_abnormal_muscle_cell | 1.03998460 |
| 69 | MP0004381_abnormal_hair_follicle | 1.02441097 |
| 70 | MP0000689_abnormal_spleen_morphology | 1.02091435 |
| 71 | MP0000747_muscle_weakness | 1.00598300 |
| 72 | MP0001851_eye_inflammation | 0.98554184 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 0.96858650 |
| 74 | MP0003448_altered_tumor_morphology | 0.96256823 |
| 75 | MP0004808_abnormal_hematopoietic_stem | 0.92951115 |
| 76 | MP0004233_abnormal_muscle_weight | 0.91593572 |
| 77 | MP0000751_myopathy | 0.88776601 |
| 78 | MP0000703_abnormal_thymus_morphology | 0.86463139 |
| 79 | MP0004185_abnormal_adipocyte_glucose | 0.86099209 |
| 80 | MP0004883_abnormal_blood_vessel | 0.85803818 |
| 81 | MP0005666_abnormal_adipose_tissue | 0.83885969 |
| 82 | MP0005390_skeleton_phenotype | 0.83027766 |
| 83 | MP0002396_abnormal_hematopoietic_system | 0.82937056 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 0.82445578 |
| 85 | MP0003221_abnormal_cardiomyocyte_apopto | 0.80253676 |
| 86 | MP0004036_abnormal_muscle_relaxation | 0.78794849 |
| 87 | MP0003045_fibrosis | 0.78696353 |
| 88 | MP0000750_abnormal_muscle_regeneration | 0.78650773 |
| 89 | MP0008874_decreased_physiological_sensi | 0.77636088 |
| 90 | MP0003329_amyloid_beta_deposits | 0.77210401 |
| 91 | MP0003279_aneurysm | 0.77132645 |
| 92 | MP0002132_abnormal_respiratory_system | 0.77085807 |
| 93 | MP0003866_abnormal_defecation | 0.76482182 |
| 94 | MP0002254_reproductive_system_inflammat | 0.76325751 |
| 95 | MP0004087_abnormal_muscle_fiber | 0.75964025 |
| 96 | MP0000249_abnormal_blood_vessel | 0.74289118 |
| 97 | MP0005164_abnormal_response_to | 0.73789540 |
| 98 | MP0010234_abnormal_vibrissa_follicle | 0.72707255 |
| 99 | MP0000767_abnormal_smooth_muscle | 0.70796524 |
| 100 | MP0010630_abnormal_cardiac_muscle | 0.70531761 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.21052759 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.48160437 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.40242288 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.35077969 |
| 5 | Orchitis (HP:0100796) | 3.64253239 |
| 6 | Myositis (HP:0100614) | 3.61755158 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.58300218 |
| 8 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.42203567 |
| 9 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.42203567 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 3.42203567 |
| 11 | Optic neuritis (HP:0100653) | 3.27514926 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 3.27514926 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 3.23889476 |
| 14 | Spontaneous hematomas (HP:0007420) | 3.14966473 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 3.07139611 |
| 16 | Increased IgE level (HP:0003212) | 2.95074395 |
| 17 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.94128696 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 2.86193370 |
| 19 | Obstructive lung disease (HP:0006536) | 2.86193370 |
| 20 | Gingivitis (HP:0000230) | 2.85673166 |
| 21 | Recurrent fungal infections (HP:0002841) | 2.82987560 |
| 22 | Recurrent skin infections (HP:0001581) | 2.81939887 |
| 23 | Cellulitis (HP:0100658) | 2.80118191 |
| 24 | Exercise-induced myalgia (HP:0003738) | 2.75112486 |
| 25 | Meningitis (HP:0001287) | 2.71036982 |
| 26 | Systemic lupus erythematosus (HP:0002725) | 2.68598805 |
| 27 | Dysostosis multiplex (HP:0000943) | 2.65135811 |
| 28 | Loss of speech (HP:0002371) | 2.62614423 |
| 29 | Colitis (HP:0002583) | 2.61626056 |
| 30 | Asymmetric septal hypertrophy (HP:0001670) | 2.60968584 |
| 31 | Amyloidosis (HP:0011034) | 2.52477201 |
| 32 | Gastrointestinal infarctions (HP:0005244) | 2.48825553 |
| 33 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.43852984 |
| 34 | Recurrent cutaneous fungal infections (HP:0011370) | 2.43852984 |
| 35 | Stomatitis (HP:0010280) | 2.43648303 |
| 36 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.43013617 |
| 37 | Increased connective tissue (HP:0009025) | 2.39980347 |
| 38 | Muscle fiber inclusion bodies (HP:0100299) | 2.36149311 |
| 39 | Keratoconjunctivitis sicca (HP:0001097) | 2.35491122 |
| 40 | Distal lower limb muscle weakness (HP:0009053) | 2.34749981 |
| 41 | Recurrent viral infections (HP:0004429) | 2.32350603 |
| 42 | Vasculitis (HP:0002633) | 2.32179011 |
| 43 | Difficulty running (HP:0009046) | 2.30602728 |
| 44 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.29903766 |
| 45 | Gastrointestinal inflammation (HP:0004386) | 2.28951083 |
| 46 | Nemaline bodies (HP:0003798) | 2.28948001 |
| 47 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.28897291 |
| 48 | Urticaria (HP:0001025) | 2.27953570 |
| 49 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.27166699 |
| 50 | Inflammation of the large intestine (HP:0002037) | 2.24267750 |
| 51 | Vacuolated lymphocytes (HP:0001922) | 2.21290989 |
| 52 | Chest pain (HP:0100749) | 2.20844270 |
| 53 | Axonal loss (HP:0003447) | 2.20611441 |
| 54 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.18371717 |
| 55 | Increased variability in muscle fiber diameter (HP:0003557) | 2.17381160 |
| 56 | Disinhibition (HP:0000734) | 2.17236373 |
| 57 | Muscle fiber splitting (HP:0003555) | 2.15420326 |
| 58 | Neuronal loss in central nervous system (HP:0002529) | 2.10330446 |
| 59 | Distal lower limb amyotrophy (HP:0008944) | 2.10296976 |
| 60 | Type 1 muscle fiber predominance (HP:0003803) | 2.09779705 |
| 61 | Hemoptysis (HP:0002105) | 2.07752457 |
| 62 | Obstructive sleep apnea (HP:0002870) | 2.07614660 |
| 63 | Keratoconjunctivitis (HP:0001096) | 2.04893345 |
| 64 | Arterial thrombosis (HP:0004420) | 2.04102041 |
| 65 | Pulmonary infiltrates (HP:0002113) | 2.03146438 |
| 66 | Interstitial pulmonary disease (HP:0006530) | 2.01879300 |
| 67 | Purpura (HP:0000979) | 2.01830402 |
| 68 | Myopathic facies (HP:0002058) | 2.01366710 |
| 69 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.01318971 |
| 70 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.01318971 |
| 71 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.01318971 |
| 72 | Encephalitis (HP:0002383) | 2.00233974 |
| 73 | Cerebral aneurysm (HP:0004944) | 1.99863990 |
| 74 | Increased serum ferritin (HP:0003281) | 1.98052582 |
| 75 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.95959189 |
| 76 | Mucopolysacchariduria (HP:0008155) | 1.94498458 |
| 77 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.94498458 |
| 78 | Hyporeflexia of lower limbs (HP:0002600) | 1.93349612 |
| 79 | Prolonged bleeding time (HP:0003010) | 1.93249465 |
| 80 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.92939343 |
| 81 | Abnormality of the endocardium (HP:0004306) | 1.92517359 |
| 82 | Epistaxis (HP:0000421) | 1.92319239 |
| 83 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.91866042 |
| 84 | Neurofibrillary tangles (HP:0002185) | 1.91394066 |
| 85 | Pustule (HP:0200039) | 1.91216368 |
| 86 | Gastrointestinal stroma tumor (HP:0100723) | 1.87365494 |
| 87 | Restrictive lung disease (HP:0002091) | 1.86668621 |
| 88 | EMG: myopathic abnormalities (HP:0003458) | 1.86585824 |
| 89 | Osteomyelitis (HP:0002754) | 1.84046905 |
| 90 | Thoracic kyphosis (HP:0002942) | 1.83333732 |
| 91 | Thin bony cortex (HP:0002753) | 1.82864932 |
| 92 | Pulmonary embolism (HP:0002204) | 1.82742186 |
| 93 | Abnormality of the fingertips (HP:0001211) | 1.82222962 |
| 94 | Bulbar palsy (HP:0001283) | 1.80657310 |
| 95 | Autoimmune thrombocytopenia (HP:0001973) | 1.78761915 |
| 96 | Slow saccadic eye movements (HP:0000514) | 1.78241074 |
| 97 | Polygenic inheritance (HP:0010982) | 1.77885035 |
| 98 | Malnutrition (HP:0004395) | 1.75387573 |
| 99 | Hematochezia (HP:0002573) | 1.75099318 |
| 100 | Upper motor neuron abnormality (HP:0002127) | 1.74986773 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.27682386 |
| 2 | ERN1 | 3.13002282 |
| 3 | PRPF4B | 3.10494428 |
| 4 | TRIB3 | 2.98756241 |
| 5 | MAP2K3 | 2.63686253 |
| 6 | MAP4K1 | 2.49174501 |
| 7 | BLK | 2.42496538 |
| 8 | TYK2 | 2.25361884 |
| 9 | IRAK3 | 2.17891333 |
| 10 | IRAK4 | 2.02540106 |
| 11 | RIPK1 | 1.97369644 |
| 12 | CSK | 1.93569627 |
| 13 | TTN | 1.81814036 |
| 14 | SIK1 | 1.78496710 |
| 15 | MAP3K13 | 1.77902323 |
| 16 | MAP3K14 | 1.77290921 |
| 17 | TAOK1 | 1.70783726 |
| 18 | SMG1 | 1.64384529 |
| 19 | ZAP70 | 1.63567898 |
| 20 | MAP3K3 | 1.62156832 |
| 21 | TBK1 | 1.58762412 |
| 22 | FGR | 1.51639459 |
| 23 | EPHB1 | 1.50296541 |
| 24 | ICK | 1.46563436 |
| 25 | FES | 1.44319294 |
| 26 | MAP3K11 | 1.43684533 |
| 27 | CDK12 | 1.43426404 |
| 28 | CDC42BPA | 1.39414727 |
| 29 | JAK3 | 1.37750459 |
| 30 | MAP3K1 | 1.37055032 |
| 31 | TNK2 | 1.36123313 |
| 32 | MARK2 | 1.26941120 |
| 33 | FGFR4 | 1.26922023 |
| 34 | KSR2 | 1.24695847 |
| 35 | TAOK2 | 1.22110959 |
| 36 | TGFBR2 | 1.17824274 |
| 37 | MAP3K10 | 1.17342620 |
| 38 | MATK | 1.15879807 |
| 39 | EEF2K | 1.14936493 |
| 40 | OBSCN | 1.14544119 |
| 41 | IRAK2 | 1.14251985 |
| 42 | IKBKE | 1.13761927 |
| 43 | HCK | 1.12626009 |
| 44 | BTK | 1.12209120 |
| 45 | JAK1 | 1.05639710 |
| 46 | CSF1R | 1.03021602 |
| 47 | MAPK12 | 1.01540532 |
| 48 | PKN2 | 0.99655826 |
| 49 | SYK | 0.94158668 |
| 50 | PDPK1 | 0.92198600 |
| 51 | MOS | 0.91458497 |
| 52 | JAK2 | 0.90875639 |
| 53 | PTK6 | 0.89307705 |
| 54 | SIK2 | 0.89121767 |
| 55 | SIK3 | 0.85600810 |
| 56 | GRK6 | 0.83543140 |
| 57 | PRKD2 | 0.80092428 |
| 58 | PDK1 | 0.79279958 |
| 59 | MAP3K7 | 0.78151663 |
| 60 | MAPK7 | 0.75809753 |
| 61 | RPS6KA2 | 0.75473410 |
| 62 | RPS6KC1 | 0.74966470 |
| 63 | RPS6KL1 | 0.74966470 |
| 64 | IKBKB | 0.74429036 |
| 65 | LYN | 0.73865673 |
| 66 | MAP3K6 | 0.73398125 |
| 67 | SGK3 | 0.72385025 |
| 68 | CAMK1D | 0.71585094 |
| 69 | MARK3 | 0.71531953 |
| 70 | GRK7 | 0.66917962 |
| 71 | ARAF | 0.64275920 |
| 72 | DDR2 | 0.64127552 |
| 73 | LCK | 0.64091304 |
| 74 | HIPK2 | 0.63986706 |
| 75 | NME2 | 0.62868069 |
| 76 | IRAK1 | 0.61837771 |
| 77 | FGFR3 | 0.61425321 |
| 78 | DYRK1B | 0.58077048 |
| 79 | RET | 0.56287329 |
| 80 | RPS6KA6 | 0.55431647 |
| 81 | STK10 | 0.54986019 |
| 82 | YES1 | 0.54221045 |
| 83 | LRRK2 | 0.51203258 |
| 84 | KIT | 0.50613239 |
| 85 | MTOR | 0.49780855 |
| 86 | PDGFRA | 0.49074510 |
| 87 | TYRO3 | 0.49003161 |
| 88 | TESK2 | 0.48601107 |
| 89 | ITK | 0.47423788 |
| 90 | CHUK | 0.46446903 |
| 91 | BMX | 0.42264129 |
| 92 | PRKG2 | 0.42211543 |
| 93 | PDGFRB | 0.41756038 |
| 94 | MAP2K6 | 0.40970208 |
| 95 | MAPK4 | 0.40714785 |
| 96 | CDK4 | 0.40410634 |
| 97 | PIK3CG | 0.40032267 |
| 98 | MAP2K4 | 0.40001347 |
| 99 | MAP3K8 | 0.39493184 |
| 100 | FYN | 0.39465694 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.59825214 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.41423032 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.32319965 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.21816515 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.11587281 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.10011279 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.91550944 |
| 8 | Tuberculosis_Homo sapiens_hsa05152 | 1.89606882 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.87487816 |
| 10 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.79073235 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.56189643 |
| 12 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.55906987 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.54271090 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.52834955 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 1.51684086 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49885627 |
| 17 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.47312444 |
| 18 | Influenza A_Homo sapiens_hsa05164 | 1.46619819 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.40805938 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.39402875 |
| 21 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39335683 |
| 22 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.37539828 |
| 23 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.34676904 |
| 24 | Lysosome_Homo sapiens_hsa04142 | 1.34350681 |
| 25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.34117828 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.33774781 |
| 27 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.31583687 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30971475 |
| 29 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.30374755 |
| 30 | Pertussis_Homo sapiens_hsa05133 | 1.29930504 |
| 31 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.29025303 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.28819681 |
| 33 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.25953888 |
| 34 | Measles_Homo sapiens_hsa05162 | 1.25506598 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.21502231 |
| 36 | Legionellosis_Homo sapiens_hsa05134 | 1.21316451 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 1.18835886 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.16412428 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.15263748 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.14315365 |
| 41 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.13850454 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.13095865 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.12202985 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 1.12087377 |
| 45 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.11073229 |
| 46 | Phagosome_Homo sapiens_hsa04145 | 1.04666015 |
| 47 | Amoebiasis_Homo sapiens_hsa05146 | 1.02696684 |
| 48 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.02096778 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.02040595 |
| 50 | Bladder cancer_Homo sapiens_hsa05219 | 0.99815282 |
| 51 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.99594709 |
| 52 | Platelet activation_Homo sapiens_hsa04611 | 0.97255080 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96979699 |
| 54 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.96743777 |
| 55 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.96707994 |
| 56 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.95992658 |
| 57 | Endometrial cancer_Homo sapiens_hsa05213 | 0.95883083 |
| 58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.95262776 |
| 59 | Asthma_Homo sapiens_hsa05310 | 0.94658380 |
| 60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.91517004 |
| 61 | Apoptosis_Homo sapiens_hsa04210 | 0.91098270 |
| 62 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.90385019 |
| 63 | Shigellosis_Homo sapiens_hsa05131 | 0.87784673 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85384222 |
| 65 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.85312560 |
| 66 | Prion diseases_Homo sapiens_hsa05020 | 0.84660928 |
| 67 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.84452454 |
| 68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83614969 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82411904 |
| 70 | Insulin resistance_Homo sapiens_hsa04931 | 0.81517047 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78210686 |
| 72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.77512921 |
| 73 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73473629 |
| 74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70036958 |
| 75 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69490329 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.69414990 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68890257 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.68122644 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68071156 |
| 80 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.67961186 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67657432 |
| 82 | Glioma_Homo sapiens_hsa05214 | 0.65199488 |
| 83 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64702936 |
| 84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58597871 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58219646 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57728309 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57470504 |
| 88 | Prostate cancer_Homo sapiens_hsa05215 | 0.56256271 |
| 89 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56067867 |
| 90 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55972305 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55927195 |
| 92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55720739 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55529237 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55147260 |
| 95 | Colorectal cancer_Homo sapiens_hsa05210 | 0.54501414 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53912174 |
| 97 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52264576 |
| 98 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52072958 |
| 99 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.50781708 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49971154 |

